So some random thoughts because it's so quiet at the moment:
- With $30m in the kitty, I wonder what investors they are presenting to this week, and why?
- I was really expecting to have some NOX COVID results by now. Very dissapointing that nothing has been released.
- Good to see Pharmorage is still getting some airtime, given that lapsed patent.
- The NOX graphic design dept. are really getting better.
- Loving this strategy as a shareholder; seems well thought out to maximise value
Ann: Noxopharm Corporate Presentation, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
